Beam Therapeutics Inc.BEAMNASDAQ
Loading
BEAM Revenue Growth (YoY Quarterly)•+279.52%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+279.52%
+311.6pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+24.21%
-0.3pp
+26.69%
+2.2pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -90.49% | +0.81% | -28.08% | -32.03% | +279.52% |
| Gross Profit Growth | -140.53% | +0.00% | -892.49% | +0.00% | +0.00% |
| EBITDA Growth | -168.44% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | -175.30% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -163.27% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -161.58% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -163.01% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.43% | +7.68% | +23.91% | +24.46% | +24.21% |
| Weighted Average Shares Diluted Growth | +0.15% | +7.68% | +23.91% | +24.46% | +26.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -156.54% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -160.34% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -24.38% | +7.88% | +10.30% | +11.93% | +34.19% |
| Book Value per Share Growth | -27.02% | +14.18% | -1.09% | -1.92% | +35.91% |
| Debt Growth | -6.52% | -5.94% | -6.31% | -6.57% | +82.05% |
| R&D Expense Growth | -27.58% | +16.50% | +16.91% | +16.46% | -2.14% |
| SG&A Expenses Growth | -33.74% | +4.55% | -9.34% | +0.85% | -7.15% |
1 / 4